Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma

Mateusz Opyrchal, Travis Figanbaum, Amit Ghosh, S Vincent Rajkumar, Sean Caples

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Tumor lysis syndrome (TLS) presenting in absence of chemotherapy is a rare occurrence. One of the true oncological emergencies, it can lead to significant morbidity and mortality. TLS is a phenomena usually associated with tumor cell death after treatment. The etiology of the spontaneous TLS is not well understood, which complicates the diagnosis. TLS is well known to oncologists but physicians outside of this specialty have little or no experience with this condition. Early recognition and treatment are the keys to limiting the sequela of the condition. Spontaneous tumor lysis syndrome is rare but presents added risks to the patient because of the potential for delayed diagnosis and no benefit of pretreatment. Diagnosis may be further delayed because this may be the first symptom of underlying malignancy. Therefore, it is imperative that all clinicians are familiar with the syndrome to assure timely recognition.

Original languageEnglish (US)
Article number610969
JournalCase Reports in Medicine
Volume2010
DOIs
StatePublished - 2010

Fingerprint

Tumor Lysis Syndrome
B-Cell Lymphoma
Delayed Diagnosis
Neoplasms
Emergencies
Cell Death
Morbidity
Physicians
Drug Therapy
Mortality
Therapeutics

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma. / Opyrchal, Mateusz; Figanbaum, Travis; Ghosh, Amit; Rajkumar, S Vincent; Caples, Sean.

In: Case Reports in Medicine, Vol. 2010, 610969, 2010.

Research output: Contribution to journalArticle

Opyrchal, Mateusz ; Figanbaum, Travis ; Ghosh, Amit ; Rajkumar, S Vincent ; Caples, Sean. / Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma. In: Case Reports in Medicine. 2010 ; Vol. 2010.
@article{19cf634bad554c30af2d20ee9ce4328f,
title = "Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma",
abstract = "Tumor lysis syndrome (TLS) presenting in absence of chemotherapy is a rare occurrence. One of the true oncological emergencies, it can lead to significant morbidity and mortality. TLS is a phenomena usually associated with tumor cell death after treatment. The etiology of the spontaneous TLS is not well understood, which complicates the diagnosis. TLS is well known to oncologists but physicians outside of this specialty have little or no experience with this condition. Early recognition and treatment are the keys to limiting the sequela of the condition. Spontaneous tumor lysis syndrome is rare but presents added risks to the patient because of the potential for delayed diagnosis and no benefit of pretreatment. Diagnosis may be further delayed because this may be the first symptom of underlying malignancy. Therefore, it is imperative that all clinicians are familiar with the syndrome to assure timely recognition.",
author = "Mateusz Opyrchal and Travis Figanbaum and Amit Ghosh and Rajkumar, {S Vincent} and Sean Caples",
year = "2010",
doi = "10.1155/2010/610969",
language = "English (US)",
volume = "2010",
journal = "Case Reports in Medicine",
issn = "1687-9627",
publisher = "Hindawi Limited",

}

TY - JOUR

T1 - Spontaneous tumor lysis syndrome in the setting of B-cell lymphoma

AU - Opyrchal, Mateusz

AU - Figanbaum, Travis

AU - Ghosh, Amit

AU - Rajkumar, S Vincent

AU - Caples, Sean

PY - 2010

Y1 - 2010

N2 - Tumor lysis syndrome (TLS) presenting in absence of chemotherapy is a rare occurrence. One of the true oncological emergencies, it can lead to significant morbidity and mortality. TLS is a phenomena usually associated with tumor cell death after treatment. The etiology of the spontaneous TLS is not well understood, which complicates the diagnosis. TLS is well known to oncologists but physicians outside of this specialty have little or no experience with this condition. Early recognition and treatment are the keys to limiting the sequela of the condition. Spontaneous tumor lysis syndrome is rare but presents added risks to the patient because of the potential for delayed diagnosis and no benefit of pretreatment. Diagnosis may be further delayed because this may be the first symptom of underlying malignancy. Therefore, it is imperative that all clinicians are familiar with the syndrome to assure timely recognition.

AB - Tumor lysis syndrome (TLS) presenting in absence of chemotherapy is a rare occurrence. One of the true oncological emergencies, it can lead to significant morbidity and mortality. TLS is a phenomena usually associated with tumor cell death after treatment. The etiology of the spontaneous TLS is not well understood, which complicates the diagnosis. TLS is well known to oncologists but physicians outside of this specialty have little or no experience with this condition. Early recognition and treatment are the keys to limiting the sequela of the condition. Spontaneous tumor lysis syndrome is rare but presents added risks to the patient because of the potential for delayed diagnosis and no benefit of pretreatment. Diagnosis may be further delayed because this may be the first symptom of underlying malignancy. Therefore, it is imperative that all clinicians are familiar with the syndrome to assure timely recognition.

UR - http://www.scopus.com/inward/record.url?scp=79955623578&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955623578&partnerID=8YFLogxK

U2 - 10.1155/2010/610969

DO - 10.1155/2010/610969

M3 - Article

AN - SCOPUS:79955623578

VL - 2010

JO - Case Reports in Medicine

JF - Case Reports in Medicine

SN - 1687-9627

M1 - 610969

ER -